课题基金 / 基金详情

Novel Enabling Technologies for Regenerative Medicine and Tissue Engineering

Novel Enabling Technologies for Regenerative Medicine and Tissue Engineering
再生医学和组织工程的新型使能技术
批准号:
288130-2012
负责人:
Mequanint, Kibret
金额:
$2.99万
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2015
资助国家:
加拿大
项目状态:
已结题
起止时间:
2015-01-01 至 2016-12-31

项目摘要

项目成果

Mequanint, Kibret的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Cardiovascular diseases such as coronary artery occlusion is one of the leading causes of death in Canada. For patients with severe coronary artery disease, there are three treatment options: (i) coronary artery bypass grafting, (ii) catheter based interventions such as coronary angioplasty and stenting, and (iii) therapeutic angiogenesis. Each of these options has its own drawback impeding the full clinical potential. The success of surgical bypass grafting is limited by the lack of an engineered biological tissue substitute whereas coronary angioplasty and stenting is limited by the undesired and uncontrolled proliferation of smooth muscle cells that eventually re-occlude the artery. Therapeutic angiogenesis requires controlled delivery of growth factors into the desired site and thus has not been possible as yet. Over the next 5 years, my research program will focus on developing novel enabling technologies to address the above-listed limitations by 1) enhancing oxygen delivery to accelerate tissue engineered vascular grafts, 2) functional immobilization of Jagged1 protein to stent-mimic surfaces, and 3) designing biodegradable amino acid derived fibrous matrix for delivery of angiogenic factors. The proposed research builds on the strengths of past interdisciplinary research efforts undertaken by the applicant and his collaborators bridging chemical engineering, materials science, and cellular and molecular biology. The motivation of the proposed research program is to obtain the understanding required to develop the next generation of technologies for applications in future vascular disease interventions and garner fundamental expertise in this area. The key objective is to train well-rounded graduates with sound technical, scientific, leadership, and entrepreneurial skills groomed by integrated interdisciplinary comprehensive research training program. Overall, the program will provide training for 3 PhD, 2 MESc and number of undergraduate students by exposing them to cutting-edge research. This research is expected to result in significant technology development for applications in future human health and economic benefit to Canada.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Instructive Biomaterials-based Platforms for Tissue Engineering and Regenerative Medicine
  • 批准号:
    RGPIN-2018-06310
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $4.66万
  • 财政年份:
    2022
  • 负责人:
    Mequanint, Kibret
  • 依托单位:
Instructive Biomaterials-based Platforms for Tissue Engineering and Regenerative Medicine
  • 批准号:
    RGPIN-2018-06310
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $4.66万
  • 财政年份:
    2021
  • 负责人:
    Mequanint, Kibret
  • 依托单位:
Instructive Biomaterials-based Platforms for Tissue Engineering and Regenerative Medicine
  • 批准号:
    RGPIN-2018-06310
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $4.66万
  • 财政年份:
    2020
  • 负责人:
    Mequanint, Kibret
  • 依托单位:
Instructive Biomaterials-based Platforms for Tissue Engineering and Regenerative Medicine
  • 批准号:
    RGPIN-2018-06310
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $4.66万
  • 财政年份:
    2019
  • 负责人:
    Mequanint, Kibret
  • 依托单位:
海外基金